{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:14:54Z","timestamp":1792721694442,"version":"4.5.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T00:00:00Z","timestamp":1514937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T00:00:00Z","timestamp":1514937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/nrrheum.2017.208","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T04:37:00Z","timestamp":1514954220000},"page":"107-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":383,"title":["Beh\u00e7et syndrome: a contemporary view"],"prefix":"10.1038","volume":"14","author":[{"given":"Hasan","family":"Yazici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emire","family":"Seyahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulen","family":"Hatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"BFnrrheum2017208_CR1","doi-asserted-by":"crossref","unstructured":"International Study Group for Beh\u00e7et's Disease. Criteria for diagnosis of Beh\u00e7et's disease. Lancet 335, 1078\u20131080 (1990).","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"BFnrrheum2017208_CR2","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.3748\/wjg.v21.i13.3801","volume":"21","author":"W Skef","year":"2015","unstructured":"Skef, W. Gastrointestinal Beh\u00e7et's disease: a review. World J. Gastroenterol. 21, 3801 (2015).","journal-title":"World J. Gastroenterol."},{"key":"BFnrrheum2017208_CR3","first-page":"338","volume":"28","author":"F Davatchi","year":"2013","unstructured":"Davatchi, F. et al. The International Criteria for Beh\u00e7et's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J. Eur. Acad. Dermatol. Venereol. 28, 338\u2013347 (2013).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"BFnrrheum2017208_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/BOR.0000000000000230","volume":"28","author":"H Yazici","year":"2016","unstructured":"Yazici, H. & Yazici, Y. Diagnosis and\/or classification of vasculitis. Curr. Opin. Rheumatol. 28, 3\u20137 (2016).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2017208_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12016-012-8319-x","volume":"43","author":"H Yazici","year":"2012","unstructured":"Yazici, H., Ugurlu, S. & Seyahi, E. Beh\u00e7et syndrome: is it one condition? Clin. Rev. Allergy Immunol. 43, 275\u2013280 (2012).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"BFnrrheum2017208_CR6","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/ard.2003.018515","volume":"63","author":"R Tunc","year":"2004","unstructured":"Tunc, R., Saip, S., Siva, A. & Yazici, H. Cerebral venous thrombosis is associated with major vessel disease in Beh\u00e7et's syndrome. Ann. Rheum. Dis. 63, 1693\u20131694 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2017208_CR7","first-page":"2393","volume":"29","author":"R Tunc","year":"2002","unstructured":"Tunc, R., Keyman, E., Melikoglu, M., Fresko, I. & Yazici, H. Target organ associations in Turkish patients with Beh\u00e7et's disease: a cross sectional study by exploratory factor analysis. J. Rheumatol. 29, 2393\u20132396 (2002).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2017208_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3109\/09273948.2013.854393","volume":"22","author":"I Tugal-Tutkun","year":"2013","unstructured":"Tugal-Tutkun, I., Onal, S., Ozyazgan, Y., Soylu, M. & Akman, M. Validity and agreement of uveitis experts in interpretation of ocular photographs for diagnosis of Beh\u00e7et uveitis. Ocul. Immunol. Inflamm. 22, 461\u2013468 (2013).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"BFnrrheum2017208_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1365-4632.2006.02859.x","volume":"45","author":"MC Mat","year":"2006","unstructured":"Mat, M. C., Goksugur, N., Engin, B., Yurdakul, S. & Yazici, H. The frequency of scarring after genital ulcers in Beh\u00e7et's syndrome: a prospective study. Int. J. Dermatol. 45, 554\u2013556 (2006).","journal-title":"Int. J. Dermatol."},{"key":"BFnrrheum2017208_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","volume":"82","author":"E Kural-Seyahi","year":"2003","unstructured":"Kural-Seyahi, E. et al. The long-term mortality and morbidity of Beh\u00e7et syndrome. Medicine 82, 60\u201376 (2003).","journal-title":"Medicine"},{"issue":"Suppl. 45","key":"BFnrrheum2017208_CR11","first-page":"S46","volume":"25","author":"S Yavuz","year":"2007","unstructured":"Yavuz, S. et al. Activation of neutrophils by testosterone in Beh\u00e7et's disease. Clin. Exp. Rheumatol. 25 (Suppl. 45), S46\u2013S51 (2007).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017208_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MD.0b013e318242ff37","volume":"91","author":"E Seyahi","year":"2012","unstructured":"Seyahi, E. et al. Pulmonary artery involvement and associated lung disease in Beh\u00e7et disease. Medicine 91, 35\u201348 (2012).","journal-title":"Medicine"},{"key":"BFnrrheum2017208_CR13","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1093\/rheumatology\/keu233","volume":"53","author":"K Tascilar","year":"2014","unstructured":"Tascilar, K. et al. Vascular involvement in Beh\u00e7et's syndrome: a retrospective analysis of associations and the time course. Rheumatology 53, 2018\u20132022 (2014).","journal-title":"Rheumatology"},{"key":"BFnrrheum2017208_CR14","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.semarthrit.2014.10.014","volume":"44","author":"E Seyahi","year":"2015","unstructured":"Seyahi, E. et al. An outcome survey of 43 patients with Budd-Chiari syndrome due to Beh\u00e7et's syndrome followed up at a single, dedicated center. Semin. Arthritis Rheum. 44, 602\u2013609 (2015).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum2017208_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12016-007-8064-8","volume":"35","author":"M Melikoglu","year":"2008","unstructured":"Melikoglu, M., Kural-Seyahi, E., Tascilar, K. & Yazici, H. The unique features of vasculitis in Beh\u00e7et's syndrome. Clin. Rev. Allergy Immunol. 35, 40\u201346 (2008).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"BFnrrheum2017208_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s002340050742","volume":"41","author":"O \u00c7oban","year":"1999","unstructured":"\u00c7oban, O. et al. Masked assessment of MRI findings: is it possible to differentiate neuro-Beh\u00e7et's disease from other central nervous system. Neuroradiology 41, 255\u2013260 (1999).","journal-title":"Neuroradiology"},{"key":"BFnrrheum2017208_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s004150170242","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva, A. et al. Beh\u00e7et's disease: diagnostic and prognostic aspects of neurological involvement. J. Neurol. 248, 95\u2013103 (2001).","journal-title":"J. Neurol."},{"key":"BFnrrheum2017208_CR18","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir, G., Serdaroglu, P., Tas\u00e7i, B. & The Neuro-Beh\u00e7et Study Group. Clinical patterns of neurological involvement in Beh\u00e7et's disease: evaluation of 200 patients. Brain 122, 2171\u20132182 (1999).","journal-title":"Brain"},{"key":"BFnrrheum2017208_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12969-017-0162-4","volume":"15","author":"S Valenti","year":"2017","unstructured":"Valenti, S., Gallizzi, R., De Vivo, D. & Romano, C. Intestinal Beh\u00e7et and Crohn's disease: two sides of the same coin. Pediatr. Rheumatol. 15, 33 (2017).","journal-title":"Pediatr. Rheumatol."},{"key":"BFnrrheum2017208_CR20","unstructured":"Hatemi, I. et al. Frequency of pathergy phenomenon and other features of Beh\u00e7et's syndrome among patients with inflammatory bowel disease. Clin. Exp. Rheumatol. 26, S91\u201395."},{"key":"BFnrrheum2017208_CR21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/ng.3786","volume":"49","author":"M Takeuchi","year":"2017","unstructured":"Takeuchi, M. et al. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Beh\u00e7et's disease susceptibility. Nat. Genet. 49, 438\u2013443 (2017).","journal-title":"Nat. Genet."},{"key":"BFnrrheum2017208_CR22","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/art.23450","volume":"58","author":"G Hatemi","year":"2008","unstructured":"Hatemi, G., Fresko, I., Tascilar, K. & Yazici, H. Increased enthesopathy among Beh\u00e7et's syndrome patients with acne and arthritis: An ultrasonography study. Arthritis Rheum. 58, 1539\u20131545 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2017208_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00005792-197409000-00002","volume":"53","author":"JMH Moll","year":"1974","unstructured":"Moll, J. M. H., Haslock, I. A. N., Macrae, I. F. & Wright, V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome. Medicine 53, 343\u2013364 (1974).","journal-title":"Medicine"},{"key":"BFnrrheum2017208_CR24","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","volume":"11","author":"D McGonagle","year":"2015","unstructured":"McGonagle, D., Aydin, S. Z., G\u00fcl, A., Mahr, A. & Direskeneli, H. 'MHC-I-opathy' \u2014 unified concept for spondyloarthritis and Beh\u00e7et disease. Nat. Rev. Rheumatol. 11, 731\u2013740 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2017208_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","volume":"13","author":"G Schett","year":"2017","unstructured":"Schett, G. et al. Enthesitis: from pathophysiology to treatment. Nat. Rev. Rheumatol. 13, 731\u2013741 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2017208_CR26","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","volume":"44","author":"S Yurdakul","year":"2001","unstructured":"Yurdakul, S. et al. A double-blind trial of colchicine in Beh\u00e7et's syndrome. Arthritis Rheum. 44, 2686\u20132692 (2001).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2017208_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","volume":"128","author":"V Hamuryudan","year":"1998","unstructured":"Hamuryudan, V. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. Ann. Intern. Med. 128, 443 (1998).","journal-title":"Ann. Intern. Med."},{"key":"BFnrrheum2017208_CR28","first-page":"98","volume":"32","author":"M Melikoglu","year":"2005","unstructured":"Melikoglu, M. et al. Short-term trial of etanercept in Beh\u00e7et's disease: a double blind, placebo controlled study. J. Rheumatol. 32, 98\u2013105 (2005).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2017208_CR29","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/rheumatology\/kel329","volume":"45","author":"H Direskeneli","year":"2006","unstructured":"Direskeneli, H. Autoimmunity versus autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology 45, 1461\u20131465 (2006).","journal-title":"Rheumatology"},{"key":"BFnrrheum2017208_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08830189709116840","volume":"14","author":"H Yazici","year":"1997","unstructured":"Yazici, H. The place of Beh\u00e7et's syndrome among the autoimmune diseases. Int. Rev. Immunol. 14, 1\u201310 (1997).","journal-title":"Int. Rev. Immunol."},{"key":"BFnrrheum2017208_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jaut.2017.08.002","volume":"84","author":"S Lule","year":"2017","unstructured":"Lule, S. et al. Beh\u00e7et disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger. J. Autoimmun. 84, 87\u201396 (2017).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum2017208_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/1568010053622894","volume":"4","author":"A Gul","year":"2005","unstructured":"Gul, A. Beh\u00e7ets disease as an autoinflammatory disorder. Curr. Drug Targets Inflamm. Allergy 4, 81\u201383 (2005).","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"BFnrrheum2017208_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/02713689208999531","volume":"11","author":"WA Franks","year":"1992","unstructured":"Franks, W. A. et al. Cytokines in human intraocular inflammation. Curr. Eye Res. 11, 187\u2013191 (1992).","journal-title":"Curr. Eye Res."},{"key":"BFnrrheum2017208_CR34","doi-asserted-by":"publisher","first-page":"8134","DOI":"10.1073\/pnas.1306352110","volume":"110","author":"Y Kirino","year":"2013","unstructured":"Kirino, Y. et al. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Beh\u00e7et disease. Proc. Natl Acad. Sci. USA 110, 8134\u20138139 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"Suppl. 38","key":"BFnrrheum2017208_CR35","first-page":"S1","volume":"23","author":"H Yazici","year":"2005","unstructured":"Yazici, H. & Fresko, I. Beh\u00e7et's disease and other autoinflammatory conditions: what's in a name? Clin. Exp. Rheumatol. 23 (Suppl. 38), S1\u2013S2 (2005).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017208_CR36","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01965145 (2017)."},{"key":"BFnrrheum2017208_CR37","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/B978-0-323-06551-1.00111-1","volume-title":"Rheumatology","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit, M. in Rheumatology 5th edn (eds Hochberg, M., Silman, A., Smolen, J., Weinblatt, M. & Weisman, M.) 1123\u20131127 (Mosby Elsevier, 2011)."},{"key":"BFnrrheum2017208_CR38","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers, E. F. et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et's disease. Nat. Genet. 42, 698\u2013702 (2010).","journal-title":"Nat. Genet."},{"key":"BFnrrheum2017208_CR39","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1073\/pnas.1406575111","volume":"111","author":"MJ Ombrello","year":"2014","unstructured":"Ombrello, M. J. et al. Behcet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity. Proc. Natl Acad. Sci. USA 111, 8867\u20138872 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2017208_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ng.2520","volume":"45","author":"Y Kirino","year":"2013","unstructured":"Kirino, Y. et al. Genome-wide association analysis identifies new susceptibility loci for Beh\u00e7et's disease and epistasis between HLA-B*51 and ERAP1. Nat. Genet. 45, 202\u2013207 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrrheum2017208_CR41","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/ng.873","volume":"43","author":"DM Evans","year":"2011","unstructured":"Evans, D. M. et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 43, 761\u2013767 (2011).","journal-title":"Nat. Genet."},{"key":"BFnrrheum2017208_CR42","doi-asserted-by":"crossref","unstructured":"Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 42, 985\u2013990 (2010).","DOI":"10.1038\/ng.694"},{"key":"BFnrrheum2017208_CR43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/BOR.0b013e3283534df4","volume":"24","author":"C Ambarus","year":"2012","unstructured":"Ambarus, C., Yeremenko, N., Tak, P. P. & Baeten, D. Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory? Curr. Opin. Rheumatol. 24, 351\u2013358 (2012).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2017208_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/cei.13049","volume":"191","author":"M Giza","year":"2017","unstructured":"Giza, M., Koftori, D., Chen, L. & Bowness, P. Is Beh\u00e7et's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Beh\u00e7et's disease. Clin. Exp. Immunol. 191, 11\u201318 (2017).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum2017208_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrrheum.2015.167","volume":"12","author":"DM Schwartz","year":"2015","unstructured":"Schwartz, D. M., Bonelli, M., Gadina, M. & O'Shea, J. J. Type I\/II cytokines, JAKs, and new strategies for treating autoimmune diseases. Nat. Rev. Rheumatol. 12, 25\u201336 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2017208_CR46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/gene.2014.64","volume":"16","author":"A Tulunay","year":"2014","unstructured":"Tulunay, A. et al. Activation of the JAK\/STAT pathway in Behcet's disease. Genes Immun. 16, 170\u2013175 (2014).","journal-title":"Genes Immun."},{"key":"BFnrrheum2017208_CR47","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.berh.2011.05.002","volume":"25","author":"G Hatemi","year":"2011","unstructured":"Hatemi, G. & Yazici, H. Beh\u00e7et's syndrome and micro-organisms. Best Pract. Res. Clin. Rheumatol. 25, 389\u2013406 (2011).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"BFnrrheum2017208_CR48","first-page":"1152","volume":"105","author":"H Beh\u00e7et","year":"1937","unstructured":"Beh\u00e7et, H. \u00dcber residivierende aphtose, durch ein virus verursachte geschw\u00fcre am mund, am auge und den genitalen [German]. Dermatol. Wochenschrift. 105, 1152\u20131158 (1937).","journal-title":"Dermatol. Wochenschrift."},{"issue":"Suppl. 45","key":"BFnrrheum2017208_CR49","first-page":"S27","volume":"25","author":"G Mumcu","year":"2007","unstructured":"Mumcu, G., Inanc, N., Yavuz, S. & Direskeneli, H. The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Beh\u00e7et's disease. Clin. Exp. Rheumatol. 25 (Suppl. 45), S27\u2013S33 (2007).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017208_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.clim.2016.06.002","volume":"169","author":"P Coit","year":"2016","unstructured":"Coit, P. et al. Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Beh\u00e7et's disease. Clin. Immunol. 169, 28\u201335 (2016).","journal-title":"Clin. Immunol."},{"key":"BFnrrheum2017208_CR51","doi-asserted-by":"publisher","first-page":"27150","DOI":"10.3402\/jom.v7.27150","volume":"7","author":"N Seoudi","year":"2015","unstructured":"Seoudi, N., Bergmeier, L. A., Drobniewski, F., Paster, B. & Fortune, F. The oral mucosal and salivary microbial community of Beh\u00e7et's syndrome and recurrent aphthous stomatitis. J. Oral Microbiol. 7, 27150 (2015).","journal-title":"J. Oral Microbiol."},{"key":"BFnrrheum2017208_CR52","doi-asserted-by":"publisher","first-page":"e0153746","DOI":"10.1371\/journal.pone.0153746","volume":"11","author":"J Shimizu","year":"2016","unstructured":"Shimizu, J. et al. Bifidobacteria abundance-featured gut microbiota compositional change in patients with Behcet's disease. PLoS ONE 11, e0153746 (2016).","journal-title":"PLoS ONE"},{"key":"BFnrrheum2017208_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","volume":"14","author":"C Consolandi","year":"2015","unstructured":"Consolandi, C. et al. Beh\u00e7et's syndrome patients exhibit specific microbiome signature. Autoimmun. Rev. 14, 269\u2013276 (2015).","journal-title":"Autoimmun. Rev."},{"key":"BFnrrheum2017208_CR54","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1136\/annrheumdis-2013-204475","volume":"74","author":"JM Xavier","year":"2013","unstructured":"Xavier, J. M. et al. FUT2: filling the gap between genes and environment in Beh\u00e7et's disease? Ann. Rheum. Dis. 74, 618\u2013624 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2017208_CR55","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12016-014-8423-1","volume":"48","author":"L Maroni","year":"2014","unstructured":"Maroni, L., van de Graaf, S. F. J., Hohenester, S. D., Oude Elferink, R. P. J. & Beuers, U. Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease \u2014 a comprehensive review. Clin. Rev. Allergy Immunol. 48, 182\u2013191 (2014).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"BFnrrheum2017208_CR56","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/ni.3587","volume":"17","author":"Y Goto","year":"2016","unstructured":"Goto, Y., Uematsu, S. & Kiyono, H. Epithelial glycosylation in gut homeostasis and inflammation. Nat. Immunol. 17, 1244\u20131251 (2016).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2017208_CR57","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/art.38409","volume":"66","author":"T Hughes","year":"2014","unstructured":"Hughes, T. et al. Epigenome-wide scan identifies a treatment-responsive pattern of altered DNA methylation among cytoskeletal remodeling genes in monocytes and CD4+ T cells from patients with Beh\u00e7et's disease. Arthritis Rheumatol. 66, 1648\u20131658 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum2017208_CR58","unstructured":"Coit, P., Direskeneli, H. & Sawalha, A. H. An update on the role of epigenetics in systemic vasculitis. Curr. Opin. Rheumatol. 10.1097\/bor.0000000000000451 (2017)."},{"key":"BFnrrheum2017208_CR59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/BOR.0000000000000234","volume":"28","author":"LT Morton","year":"2016","unstructured":"Morton, L. T., Situnayake, D. & Wallace, G. R. Genetics of Beh\u00e7et's disease. Curr. Opin. Rheumatol. 28, 39\u201344 (2016).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2017208_CR60","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/rheumatology\/ker428","volume":"51","author":"C Maldini","year":"2012","unstructured":"Maldini, C., LaValley, M. P., Cheminant, M., de Menthon, M. & Mahr, A. Relationships of HLA-B51 or B5 genotype with Beh\u00e7et's disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology 51, 887\u2013900 (2012).","journal-title":"Rheumatology"},{"key":"BFnrrheum2017208_CR61","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/CIRCULATIONAHA.115.017738","volume":"133","author":"M Becatti","year":"2015","unstructured":"Becatti, M. et al. Neutrophil activation promotes fibrinogen oxidation and thrombus formation in Beh\u00e7et's disease. Circulation 133, 302\u2013311 (2015).","journal-title":"Circulation"},{"key":"BFnrrheum2017208_CR62","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","volume":"54","author":"DH Verity","year":"1999","unstructured":"Verity, D. H., Marr, J. E., Ohno, S., Wallace, G. R. & Stanford, M. R. Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54, 213\u2013220 (1999).","journal-title":"Tissue Antigens"},{"key":"BFnrrheum2017208_CR63","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3315\/jdcr.2015.1213","volume":"9","author":"M Ndiaye","year":"2015","unstructured":"Ndiaye, M. et al. Beh\u00e7et's disease in black skin. A retrospective study of 50 cases in Dakar. J. Dermatol. Case Rep. 9, 98\u2013102 (2015).","journal-title":"J. Dermatol. Case Rep."},{"key":"BFnrrheum2017208_CR64","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/rheumatology\/kes249","volume":"52","author":"A Mohammad","year":"2012","unstructured":"Mohammad, A., Mandl, T., Sturfelt, G. & Segelmark, M. Incidence, prevalence and clinical characteristics of Behcet's disease in southern Sweden. Rheumatology 52, 304\u2013310 (2012).","journal-title":"Rheumatology"},{"issue":"Suppl 42","key":"BFnrrheum2017208_CR65","first-page":"S125","volume":"24","author":"NG Papoutsis","year":"2006","unstructured":"Papoutsis, N. G. et al. Prevalence of Adamantiades-Beh\u00e7et's disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin. Exp. Rheumatol. 24 (Suppl 42), S125 (2006).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017208_CR66","first-page":"471","volume":"73","author":"JH Kappen","year":"2015","unstructured":"Kappen, J. H. et al. Beh\u00e7et's disease, hospital-based prevalence and manifestations in the Rotterdam area. Neth. J. Med. 73, 471\u2013477 (2015).","journal-title":"Neth. J. Med."},{"key":"BFnrrheum2017208_CR67","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1002\/art.24149","volume":"58","author":"A Mahr","year":"2008","unstructured":"Mahr, A. et al. Population-based prevalence study of Beh\u00e7et's disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum. 58, 3951\u20133959 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2017208_CR68","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/art.24423","volume":"61","author":"KT Calamia","year":"2009","unstructured":"Calamia, K. T. et al. Epidemiology and clinical characteristics of beh\u00e7et's disease in the US: a population-based study. Arthritis Rheum. 61, 600\u2013604 (2009).","journal-title":"Arthritis Rheum."},{"issue":"Suppl.","key":"BFnrrheum2017208_CR69","first-page":"1284","volume":"62","author":"Y Yazici","year":"2010","unstructured":"Yazici, Y., Filopoulos, M. T., Schimmel, E., McCraken, A. & Swearingen, C. Clinical characteristics, treatment and ethnic\/racial differences in the manifestations of 518 Behcet's syndrome patients in the United States [abstract]. Arthritis. Rheum. 62 (Suppl.), 1284 (2010).","journal-title":"Arthritis. Rheum."},{"key":"BFnrrheum2017208_CR70","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/art.22500","volume":"57","author":"C Salvarani","year":"2007","unstructured":"Salvarani, C. et al. Epidemiology and clinical course of Beh\u00e7et's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum. 57, 171\u2013178 (2007).","journal-title":"Arthritis Rheum."},{"issue":"Suppl.","key":"BFnrrheum2017208_CR71","first-page":"S51","volume":"35","author":"WY Madanat","year":"2017","unstructured":"Madanat, W. Y. et al. The prevalence of Beh\u00e7et disease in the north of Jordan: a hospital based epidemiological survey. Clin. Exp. Rheumatol 35 (Suppl.), S51\u2013S54 (2017).","journal-title":"Clin. Exp. Rheumatol"},{"key":"BFnrrheum2017208_CR72","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/art.27568","volume":"62","author":"D Saadoun","year":"2010","unstructured":"Saadoun, D. et al. Mortality in Beh\u00e7et's disease. Arthritis Rheum. 62, 2806\u20132812 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2017208_CR73","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/rheumatology\/keq251","volume":"49","author":"E Bernabe","year":"2010","unstructured":"Bernabe, E., Marcenes, W., Mather, J., Phillips, C. & Fortune, F. Impact of Behcet's syndrome on health-related quality of life: influence of the type and number of symptoms. Rheumatology 49, 2165\u20132171 (2010).","journal-title":"Rheumatology"},{"key":"BFnrrheum2017208_CR74","unstructured":"Buyuktas, D. et al. Fatigue is correlated with disease activity but not with the type of organ involvement in Beh\u00e7et's syndrome: a comparative clinical survey. Clin. Exp. Rheumatol. 33, S107\u2013112."},{"key":"BFnrrheum2017208_CR75","unstructured":"Ilhan, B. et al. Fatigue in patients with Behcet's syndrome: relationship with quality of life, depression, anxiety, disability and disease activity. Int. J. Rheum. Dis. 10.1111\/1756-185X.12839 (2016)."},{"issue":"Suppl. 50","key":"BFnrrheum2017208_CR76","first-page":"S110","volume":"26","author":"N Moses Alder","year":"2008","unstructured":"Moses Alder, N., Fisher, M. & Yazici, Y. Beh\u00e7et's syndrome patients have high levels of functional disability, fatigue and pain as measured by a Multi-dimensional Health Assessment Questionnaire (MDHAQ). Clin. Exp. Rheumatol. 26 (Suppl. 50), S110\u2013S113 (2008).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"Suppl. 94","key":"BFnrrheum2017208_CR77","first-page":"S30","volume":"33","author":"C Saygin","year":"2015","unstructured":"Saygin, C., Uzunaslan, D., Hatemi, G. & Hamuryudan, V. Suicidal ideation among patients with Beh\u00e7et's syndrome. Clin. Exp. Rheumatol. 33 (Suppl. 94), S30\u2013S35 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017208_CR78","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/acr.23155","volume":"69","author":"G Volle","year":"2017","unstructured":"Volle, G. et al. Dietary and nondietary triggers of oral ulcer recurrences in Beh\u00e7et's disease. Arthritis Care Res. 69, 1429\u20131436 (2017).","journal-title":"Arthritis Care Res."},{"issue":"Suppl. 72","key":"BFnrrheum2017208_CR79","first-page":"S32","volume":"30","author":"V Hamuryudan","year":"2012","unstructured":"Hamuryudan, V. et al. Frequent oral ulceration during early disease may predict a severe disease course in males with Beh\u00e7et's syndrome. Clin. Exp. Rheumatol. 30 (Suppl. 72), S32\u2013S34 (2012).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017208_CR80","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s10067-014-2585-3","volume":"33","author":"F Alibaz-Oner","year":"2014","unstructured":"Alibaz-Oner, F. et al. Unmet need in Behcet's disease: most patients in routine follow-up continue to have oral ulcers. Clin. Rheumatol. 33, 1773\u20131776 (2014).","journal-title":"Clin. Rheumatol."},{"key":"BFnrrheum2017208_CR81","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/09273948.2016.1205100","volume":"25","author":"I Tugal-Tutkun","year":"2016","unstructured":"Tugal-Tutkun, I., Ozdal, P. C., Oray, M. & Onal, S. Review for diagnostics of the year: multimodal imaging in Beh\u00e7et uveitis. Ocul. Immunol. Inflamm. 25, 7\u201319 (2016).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"BFnrrheum2017208_CR82","unstructured":"Onal, S. et al. Quantitative analysis of structural alterations in the choroid of patients with active Beh\u00e7et uveitis. Retina 10.1097\/iae.0000000000001587 (2017)."},{"key":"BFnrrheum2017208_CR83","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ajo.2014.11.029","volume":"159","author":"M Oray","year":"2015","unstructured":"Oray, M., Onal, S., Bayraktar, S., Izgi, B. & Tugal-Tutkun, I. Nonglaucomatous localized retinal nerve fiber layer defects in Beh\u00e7et uveitis. Am. J. Ophthalmol. 159, 475\u2013481.e1 (2015).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrrheum2017208_CR84","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/09273948.2014.918154","volume":"23","author":"Y-R Chung","year":"2014","unstructured":"Chung, Y.-R., Lee, E.-S., Kim, M. H., Lew, H. M. & Song, J. H. Changes in ocular manifestations of Beh\u00e7et disease in Korean patients over time: a single-center experience in the 1990s and 2000s. Ocul. Immunol. Inflamm. 23, 157\u2013161 (2014).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"BFnrrheum2017208_CR85","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3109\/09273948.2012.713159","volume":"20","author":"AK Cingu","year":"2012","unstructured":"Cingu, A. K., Onal, S., Urgancioglu, M. & Tugal-Tutkun, I. Comparison of presenting features and three-year disease course in Turkish patients with Beh\u00e7et uveitis who presented in the early 1990s and the early 2000s. Ocul. Immunol. Inflamm. 20, 423\u2013428 (2012).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"BFnrrheum2017208_CR86","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.ajo.2011.05.032","volume":"152","author":"SRJ Taylor","year":"2011","unstructured":"Taylor, S. R. J. et al. Beh\u00e7et disease: visual prognosis and factors influencing the development of visual loss. Am. J. Ophthalmol. 152, 1059\u20131066 (2011).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrrheum2017208_CR87","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/09273948.2015.1094095","volume":"25","author":"M Accorinti","year":"2016","unstructured":"Accorinti, M., Pesci, F. R., Pirraglia, M. P., Abicca, I. & Pivetti-Pezzi, P. Ocular Beh\u00e7et's disease: changing patterns over time, complications and long-term visual prognosis. Ocul. Immunol. Inflamm. 25, 29\u201336 (2016).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"BFnrrheum2017208_CR88","doi-asserted-by":"publisher","first-page":"e1899","DOI":"10.1097\/MD.0000000000001899","volume":"94","author":"E Seyahi","year":"2015","unstructured":"Seyahi, E. et al. Clinical and ultrasonographic evaluation of lower-extremity vein thrombosis in Behcet syndrome. Medicine 94, e1899 (2015).","journal-title":"Medicine"},{"key":"BFnrrheum2017208_CR89","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.rmed.2011.07.022","volume":"105","author":"E Seyahi","year":"2011","unstructured":"Seyahi, E. et al. The estimated pulmonary artery pressure can be elevated in Beh\u00e7et's syndrome. Respir. Med. 105, 1739\u20131747 (2011).","journal-title":"Respir. Med."},{"issue":"Suppl. 102","key":"BFnrrheum2017208_CR90","first-page":"92","volume":"34","author":"SN Esatoglu","year":"2016","unstructured":"Esatoglu, S. N. et al. Bronchial artery enlargement may be the cause of recurrent haemoptysis in Beh\u00e7et's syndrome patients with pulmonary artery involvement during follow-up. Clin. Exp. Rheumatol. 34 (Suppl. 102), 92\u201396 (2016).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017208_CR91","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00415-009-0145-6","volume":"256","author":"A Siva","year":"2009","unstructured":"Siva, A. & Saip, S. The spectrum of nervous system involvement in Beh\u00e7et's syndrome and its differential diagnosis. J. Neurol. 256, 513\u2013529 (2009).","journal-title":"J. Neurol."},{"key":"BFnrrheum2017208_CR92","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3109\/00207454.2012.704454","volume":"122","author":"T G\u00fcnd\u00fcz","year":"2012","unstructured":"G\u00fcnd\u00fcz, T. et al. Cognitive impairment in neuro-Behcet's disease and multiple sclerosis: a comparative study. Int. J. Neurosci. 122, 650\u2013656 (2012).","journal-title":"Int. J. Neurosci."},{"issue":"Suppl. 94","key":"BFnrrheum2017208_CR93","first-page":"S80","volume":"33","author":"G Akman-Demir","year":"2015","unstructured":"Akman-Demir, G. et al. Beh\u00e7et's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria. Clin. Exp. Rheumatol. 33 (Suppl. 94), S80\u2013S84 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017208_CR94","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jns.2013.11.020","volume":"337","author":"H Kikuchi","year":"2014","unstructured":"Kikuchi, H., Takayama, M. & Hirohata, S. Quantitative analysis of brainstem atrophy on magnetic resonance imaging in chronic progressive neuro-Beh\u00e7et's disease. J. Neurol. Sci. 337, 80\u201385 (2014).","journal-title":"J. Neurol. Sci."},{"key":"BFnrrheum2017208_CR95","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/art.38351","volume":"66","author":"N Noel","year":"2014","unstructured":"Noel, N. et al. Long-term outcome of neuro-Beh\u00e7et's disease. Arthritis Rheumatol. 66, 1306\u20131314 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum2017208_CR96","doi-asserted-by":"publisher","first-page":"e3348","DOI":"10.1097\/MD.0000000000003348","volume":"95","author":"I Hatemi","year":"2016","unstructured":"Hatemi, I. et al. Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet's syndrome. Medicine 95, e3348 (2016).","journal-title":"Medicine"},{"key":"BFnrrheum2017208_CR97","first-page":"AB0574","volume":"75","author":"SN Esatoglu","year":"2016","unstructured":"Esatoglu, S. N. et al. Fecal calprotectin level looks promising in identifying active disease in Beh\u00e7et's syndrome patients with gastrointestinal involvement: a controlled and pilot study [abstract]. Ann. Rheum. Dis. 75, AB0574 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2017208_CR98","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3899\/jrheum.131249","volume":"41","author":"G Hatemi","year":"2014","unstructured":"Hatemi, G. et al. Outcome measures used in clinical trials for Behcet syndrome: a systematic review. J. Rheumatol. 41, 599\u2013612 (2014).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2017208_CR99","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3899\/jrheum.141147","volume":"42","author":"G Hatemi","year":"2015","unstructured":"Hatemi, G. et al. Current status, goals, and research agenda for outcome measures development in Behcet syndrome: report from OMERACT 2014. J. Rheumatol. 42, 2436\u20132441 (2015).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2017208_CR100","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3899\/jrheum.161352","volume":"44","author":"G Hatemi","year":"2017","unstructured":"Hatemi, G. et al. Developing a core set of outcome measures for Beh\u00e7et disease: report from OMERACT 2016. J. Rheumatol. 44, 1750\u20131753 (2017).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2017208_CR101","unstructured":"Cush, J. New EULAR guidelines on Beh\u00e7et's. RheumNow http:\/\/rheumnow.com\/content\/new-eular-guidelines-beh%C3%A7ets (2016)."},{"issue":"Suppl. 42","key":"BFnrrheum2017208_CR102","first-page":"S83","volume":"24","author":"L Tasli","year":"2006","unstructured":"Tasli, L., Mat, C., De Simone, C. & Yazici, H. Lactobacilli lozenges in the management of oral ulcers of Beh\u00e7et's syndrome. Clin. Exp. Rheumatol. 24 (Suppl. 42), S83\u2013S86 (2006).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017208_CR103","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1056\/NEJMoa1408684","volume":"372","author":"G Hatemi","year":"2015","unstructured":"Hatemi, G. et al. Apremilast for Beh\u00e7et's syndrome \u2014 a phase 2, placebo-controlled study. N. Engl. J. Med. 372, 1510\u20131518 (2015).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2017208_CR104","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/archderm.138.4.467","volume":"138","author":"E Alpsoy","year":"2002","unstructured":"Alpsoy, E. et al. Interferon alfa-2a in the treatment of Beh\u00e7et disease: a randomized placebo-controlled and double-blind study. Arch. Dermatol. 138, 467\u2013471 (2002).","journal-title":"Arch. Dermatol."},{"key":"BFnrrheum2017208_CR105","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13075-017-1222-3","volume":"19","author":"PC Grayson","year":"2017","unstructured":"Grayson, P. C. et al. Treatment of mucocutaneous manifestations in Beh\u00e7et's disease with anakinra: a pilot open-label study. Arthritis Res. Ther. 19, 69 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2017208_CR106","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaut.2017.05.002","volume":"82","author":"A Mirouse","year":"2017","unstructured":"Mirouse, A. et al. Ustekinumab for Beh\u00e7et's disease. J. Autoimmun. 82, 41\u201346 (2017).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum2017208_CR107","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/annrheumdis-2011-155143","volume":"71","author":"A G\u00fcl","year":"2011","unstructured":"G\u00fcl, A. et al. Interleukin-1\u03b2-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Beh\u00e7et's disease: an open-label pilot study. Ann. Rheum. Dis. 71, 563\u2013566 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2017208_CR108","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3109\/09273948.2015.1092558","volume":"25","author":"I Tugal-Tutkun","year":"2016","unstructured":"Tugal-Tutkun, I. et al. Safety and efficacy of gevokizumab in patients with beh\u00e7et's disease uveitis: results of an exploratory phase 2 study. Ocul. Immunol. Inflamm. 25, 62\u201370 (2016).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"BFnrrheum2017208_CR109","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ophtha.2012.09.040","volume":"120","author":"AD Dick","year":"2013","unstructured":"Dick, A. D. et al. Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. Ophthalmology 120, 777\u2013787 (2013).","journal-title":"Ophthalmology"},{"key":"BFnrrheum2017208_CR110","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.semarthrit.2015.11.012","volume":"45","author":"A Deroux","year":"2016","unstructured":"Deroux, A., Chiquet, C. & Bouillet, L. Tocilizumab in severe and refractory Behcet's disease: four cases and literature review. Semin. Arthritis Rheum. 45, 733\u2013737 (2016).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrrheum2017208_CR111","doi-asserted-by":"crossref","unstructured":"Eser Ozturk, H., Oray, M. & Tugal-Tutkun, I. Tocilizumab for the treatment of Beh\u00e7et uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy. Ocul. Immunol. Inflamm. 10.1080\/09273948.2017.1355471 (2017).","DOI":"10.1080\/09273948.2017.1355471"},{"key":"BFnrrheum2017208_CR112","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.amjmed.2004.05.027","volume":"117","author":"V Hamuryudan","year":"2004","unstructured":"Hamuryudan, V. et al. Pulmonary artery aneurysms in Beh\u00e7et syndrome. Am. J. Med. 117, 867\u2013870 (2004).","journal-title":"Am. J. Med."},{"key":"BFnrrheum2017208_CR113","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jvs.2011.07.049","volume":"55","author":"H Tuzun","year":"2012","unstructured":"Tuzun, H. et al. Management and prognosis of nonpulmonary large arterial disease in patients with Beh\u00e7et disease. J. Vasc. Surg. 55, 157\u2013163 (2012).","journal-title":"J. Vasc. Surg."},{"key":"BFnrrheum2017208_CR114","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.semarthrit.2015.06.008","volume":"45","author":"V Hamuryudan","year":"2015","unstructured":"Hamuryudan, V. et al. Pulmonary artery involvement in Beh\u00e7et's syndrome: effects of anti-Tnf treatment. Semin. Arthritis Rheum. 45, 369\u2013373 (2015).","journal-title":"Semin. Arthritis Rheum."},{"issue":"Suppl. 95","key":"BFnrrheum2017208_CR115","first-page":"S3","volume":"34","author":"E Seyahi","year":"2016","unstructured":"Seyahi, E. & Yazici, H. To anticoagulate or not to anticoagulate vascular thrombosis in Beh\u00e7et's syndrome: an enduring question. Clin. Exp. Rheumatol. 34 (Suppl. 95), S3\u2013S4 (2016).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017208_CR116","doi-asserted-by":"publisher","first-page":"e494","DOI":"10.1097\/MD.0000000000000494","volume":"94","author":"F Alibaz-Oner","year":"2015","unstructured":"Alibaz-Oner, F. et al. Beh\u00e7et disease with vascular involvement. Medicine. 94, e494 (2015).","journal-title":"Medicine."},{"issue":"Suppl. 50","key":"BFnrrheum2017208_CR117","first-page":"S84","volume":"26","author":"G Akman-Demir","year":"2008","unstructured":"Akman-Demir, G. et al. Cyclosporine for Beh\u00e7et's uveitis: is it associated with an increased risk of neurological involvement? Clin. Exp. Rheumatol. 26 (Suppl. 50), S84\u2013S90 (2008).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017208_CR118","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1006\/clin.1996.4268","volume":"82","author":"S Hirohata","year":"1997","unstructured":"Hirohata, S. et al. Cerebrospinal fluid interleukin-6 in progressive Neuro-Beh\u00e7et's syndrome. Clin. Immunol. Immunopathol. 82, 12\u201317 (1997).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"BFnrrheum2017208_CR119","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cyto.2008.10.007","volume":"44","author":"G Akman-Demir","year":"2008","unstructured":"Akman-Demir, G. et al. Interleukin-6 in neuro-Beh\u00e7et's disease: association with disease subsets and long-term outcome. Cytokine 44, 373\u2013376 (2008).","journal-title":"Cytokine"},{"issue":"Suppl. 94","key":"BFnrrheum2017208_CR120","first-page":"S129","volume":"33","author":"I Hatemi","year":"2015","unstructured":"Hatemi, I., Hatemi, G., Pamuk, O. N., Erzin, Y. & Celik, A. F. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Beh\u00e7et's syndrome refractory to the conventional treatment modalities: a case series and review of the literature. Clin. Exp. Rheumatol. 33 (Suppl. 94), S129\u2013S137 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017208_CR121","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1093\/rheumatology\/ket479","volume":"53","author":"T Soysal","year":"2014","unstructured":"Soysal, T. et al. Bone marrow transplantation for Behcet's disease: a case report and systematic review of the literature. Rheumatology 53, 1136\u20131141 (2014).","journal-title":"Rheumatology"},{"issue":"Suppl. 102","key":"BFnrrheum2017208_CR122","first-page":"S23","volume":"34","author":"H Yazici","year":"2016","unstructured":"Yazici, H. Beh\u00e7et's syndrome in the 2000s: \u201cWhere is the wisdom we have lost in knowledge?\u201d Clin. Exp. Rheumatol. 34, (Suppl. 102) S23\u2013S25 (2016).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2017208_CR123","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-1-4419-5641-5_3","volume-title":"Beh\u00e7et's Syndrome","author":"S Yurdakul","year":"2010","unstructured":"Yurdakul, S. & Yazici, Y. in Beh\u00e7et's Syndrome 1st edn (eds Yazici, Y. & Yazici, H.) 35\u201352 (Springer, 2010)."}],"updated-by":[{"DOI":"10.1038\/nrrheum.2018.3","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000}}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2017.208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2017.208","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrrheum.2017.208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2017.208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:41:44Z","timestamp":1684471304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2017.208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,3]]},"references-count":123,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["BFnrrheum2017208"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2017.208","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/nrrheum.2018.3","asserted-by":"object"}]},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,3]]},"assertion":[{"value":"3 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original version of this article, the indicated dosage of colchicine, 1.5 mg per day, was incorrectly given as 1.5 mg\/kg per day in figure 4. This error has now been corrected in the print, PDF and HTML versions of this article.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.S. has received honoraria or speaker's fees from Pfizer, MSD, Mustafa Nevzat and UCB Pharma. G.H. has received honoraria, speaker fees and\/or research grants from Abbvie, BMS, Celgene, Mustafa Nevzat, MSD, Pfizer and UCB Pharma. Y.Y. has received research grants from BMS, Celgene and Genentech, and has received consulting fees from Celgene. H.Y. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}